In August 2020, the “Bio-enzyme Library Development and Green Catalytic Synthesis Application” project of Zhejiang Shangke Biopharmaceutical Co., Ltd. passed the preliminary review of the Zhejiang Provincial Key R&D Program of the Zhejiang Provincial Department of Science and Technology.
Zhejiang Syncozymes Bio-Pharmaceutical Co., Ltd. is located in Binhai New Area, Shaoxing, Zhejiang, covering an area of 230 acres and strategically located in the middle section of the south bank of Hangzhou Bay, with Hangzhou in the west, Ningbo in the east, and Jiaxing in the north. It mainly produces KRED/ATA/IRED/NIT/NHT/ERED series of biological enzymes, coenzyme NMN/NAD/NADH/NADP series products and Ibrutinib and other APIs and preparations.
Post time: Aug-26-2022